Table 3. Molecular subtypes of newly diagnosed breast cancers in 2018 in Korea (KBCS registry data).
Molecular subtype | No. of patients |
---|---|
HR (+), HER2 (−) | 6.226 (68.4) |
HR (+), HER2 (+) | 1.035 (11.4) |
HR (−), HER2 (−) | 838 (9.2) |
HR (−), HER2 (−) | 997 (11.0) |
Total | 9.096 (100.0) |
Values are presented as number (%).
KBCS = Korean Breast Cancer Society; HR = hormone receptor; HER2 = human epidermal growth factor receptor-2.